AstraZeneca has struck a deal to acquire biotechnology EsoBiotec for up to $1bn, as the London-listed pharmaceuticals group ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

The deal includes the Belgian biotech’s vivo cell-therapy platform, which modifies immune cells within the patient’s body, ...

Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth ...

Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share estimates for Legend Biotech in a ...

The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial ...

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...

AstraZeneca acquires EsoBiotec for $1 billion to enhance cancer treatment capabilities, with potential for revolutionary cell ...

Press Release 4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will receive USD 400 million upfront, with the potential ...

AIIMS in New Delhi is experiencing severe staff shortages, with hundreds of vacant posts for doctors and faculty members. A ...

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

The clinical-stage biopharmaceutical company saw the highest jump in retail interest after reporting positive topline data ...